Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -9 of 9 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy				Phase II				MDA-2004-0059 6132, NCI-6132, NCT00104871
	Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer				Phase II				060025 06-DK-0025, NCT00251316
	Lenalidomide in Treating Patients With Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine and Cannot Be Removed By Surgery				Phase II				UKMC-05-0701-F3R CELGENE-UKMC-05-0701-F3R, NCT00287287
	Sunitinib in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery				Phase II				UCCRC-14696A 14696A, 7735, NCI-7735, NCT00381641
	Pazopanib in Treating Patients With Advanced Thyroid Cancer				Phase II				MAYO-MC057H MC057H, 7627, NCT00625846
	Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma				Phase I				04-116 NCT00673010
	Iodine I 131 in Treating Patients With Thyroid Cancer				No phase specified				JHOC-NA_00002264 NCT00416949
	A Proof-of-Concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis				No phase specified				GE-135-003 NCT00565721
	A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoind and Peroxisome-Proliferator-Activated Receptor (PPARy) Expression				No phase specified				COMIRB# 07-0727 NCT00718770

| | | | | | | |

A Service of the National Cancer Institute